Jihong Zhang

ORCID: 0000-0002-5917-7658 · 2 papers in corpus

article 2021

Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis

Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2021/6034147

Aim. This study aimed to predict the key targets and endocrine mechanisms of Guizhi Fuling Wan (GZFLW) in treating adenomyosis (AM) through network pharmacology, molecular docking, and animal experiment verification. Methods. The related in…

article 2014

Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis.

International journal of clinical and experimental pathology

Angiogenesis is an important pathogenesis of Endometriosis. Vascular endothelial growth factor C (VEGF-C) is one of the most important factor in the regulation of both normal and abnormal angiogenesis. Anti-angiogenic treatment of endometri…